Overbought Stocks in Action- Idenix Pharmaceuticals Inc (NASDAQ:IDIX), PDL BioPharma Inc (NASDAQ:PDLI), TG Therapeutics, Inc. (NASDAQ:TGTX)
The Rosen Law Firm, P.A. is investigating the BODs of Idenix Pharmaceuticals Inc (NASDAQ:IDIX) [Trend Analysis] for potential breaches of fiduciary duties as well as other violations of law by failing to adequately shop Idenix to make the most of shareholder value before signee into an accord with Merck & Co., Inc. (MRK). MRK’s verdict to risk $3.85B of shareholder capital for IDIX “Nuc” assets was driven by its disclosure that MK-5172+MK-8742 regimens will need a “Nuc” for activity in GT 2/3. Under the terms of the projected transaction, shareholders will get $24.50 in cash for each share of Idenix stock they own. The projected transaction is valued at around $3.85B. Idenix Pharmaceuticals Inc (NASDAQ:IDIX) rose 0.17%, closing the day at $23.60 in last regular trading while in after hours trading shares moved up 0.55%. The firm has market capitalization of $3.56B.
Why Investors Show Confidence on (NASDAQ:MNKD)
PDL BioPharma Inc (NASDAQ:PDLI) [Trend Analysis]reported that it has paid the June 12, 2014, regular quarterly dividend expense of $0.15 per share to all stockholders owning shares of PDL as of June 5, 2014, the record date. Shares of PDL BioPharma Inc (NASDAQ:PDLI) increased 0.52% to the trading at $9.71. The firm has 52-week low range of $7.38 and 52-week high price was $10.20.The recommendation trends from street professionals are, stock rated at “hold” by 3 analysts, while no analyst rates as a “sell” security.
Is PDLI Going To Ascend or Descend following Active News? Find Experts View Here
The Board of Directors of TG Therapeutics, Inc. (NASDAQ:TGTX) [Trend Analysis] permitted a second amendment to the Restricted Stock Agreement of Michael S. Weiss, TG’s Chief Executive Officer, dated as of May 16, 2012 (the “Weiss Restricted Stock Agreement”). TG Therapeutics, Inc. (NASDAQ:TGTX) surged 20.82%, closing the day at $8.82, after wavering among $7.19 and $8.89 during the trading session. The stock has a 52-week high price of $8.89 and its 52-week low price was $2.97.
Why TGTX Rallied in Active Trading, Find here
Read Full Disclaimer Here